Skip to content

Blazer® II XP M0044500THK20Recalls & reported problems

Boston Scientific Corporation · Temperature Ablation Catheter · Class 3

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
8
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 8 adverse event reports that list this exact device (DI 08714729452287), received between Jan 18, 2017 and Jul 29, 2025 — classified as 8 malfunctions.

The most frequently reported specific device problem is “Break” (1 report).

1 other recall cover devices cleared under the same FDA submission (P020025); they may or may not involve this specific model.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 1 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Break1
  • Charred1
  • Device Operates Differently Than Expected1
  • Failure to Deliver Energy1
  • Failure to Sense1
  • Mechanics Altered1
  • Output below Specifications1
  • Temperature Problem1

Patient problems

  • No Consequences Or Impact To Patient5
  • No Clinical Signs, Symptoms or Conditions2
  • No Known Impact Or Consequence To Patient1

Recent adverse event reports

The 8 most recent of 8 reports, in the reporter's own words as published by the FDA.

  • MalfunctionJul 29, 2025Output below Specifications; Output below Specifications

    IT WAS REPORTED THAT THE POWER COULD NOT BE INCREASED TO 40W. DURING AN ABLATION PROCEDURE TO TREAT ATRIAL FLUTTER, A BLAZER II XP WAS SELECTED FOR USE. PRIOR TO THE PROCEDURE, DURING PREPARATION, IT WAS NOTED THAT THE POWER COULD NOT BE INCREASED TO 40W. THERE WAS NO ERROR MESSAGE DISPLAYED. SUBSEQUENTLY, ANOTHER BLAZER CATHETER WAS USED, AND THE PROCEDURE WAS COMPLETED. THERE WERE NO PATIENT COMPLICATIONS REPORTED AS A RESULT OF THIS EVENT. THE DEVICE WAS CONTAMINATED AND WILL NOT BE RETURNED FOR ANALYSIS.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 22645759 ↗
  • MalfunctionApr 15, 2021Temperature Problem; Temperature Problem

    DURING AN ABLATION PROCEDURE TO TREAT ATRIAL FLUTTER A BLAZER II XP CATHETER WAS SELECTED FOR USE. IT WAS REPORTED THAT THE TEMPERATURE REACHED 70 DEGREES CELSIUS AND IT COULD NOT BE CONTROLLED BY THE PHYSICIAN. THE PROCEDURE WAS HALTED AND THE CATHETER WAS EXCHANGED FOR ANOTHER. THE PROCEDURE WAS COMPLETED SUCCESSFULLY WITHOUT ANY PATIENT COMPLICATIONS.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 11674154 ↗
  • MalfunctionJun 26, 2019Mechanics Altered; Mechanics Altered

    IT WAS REPORTED THAT THE CURVE WOULD NOT STRAIGHTEN. DURING A RIGHT ATRIAL FLUTTER PROCEDURE INVOLVING A BLAZER II XP CATHETER WHILE INSIDE THE BODY, THE CATHETER RETAINED THE CURVE AND IT WOULD NOT STRAIGHTEN OUT AND STAYED CURVED. THE CATHETER WAS EXCHANGED AND THE PROCEDURE WAS COMPLETED WITH NO COMPLICATIONS TO THE PATIENT AND WAS FINE.

    Patient problems: No Consequences Or Impact To Patient

    MAUDE report 8735229 ↗
  • MalfunctionMay 22, 2018Charred; Charred

    IT WAS REPORTED THAT CHAR WAS NOTED AT THE TIP OF THE CATHETER. THE TARGET LESION WAS LOCATED IN THE RIGHT ATRIUM. A 7 / 110 / 2.5 / 8-8 QD K2 BLAZER PRIME® XP ABLATION CATHETER WAS SELECTED FOR RIGHT ATRIAL FLUTTER ABLATION. DURING PROCEDURE, THE RUNNING PARAMETERS WERE NORMAL, THE POWER WAS AT 80 WATTS AND THE TEMPERATURE WAS 65. HOWEVER, WHEN THE CASE WAS COMPLETED AND THE CATHETER WAS THEN REMOVED FROM THE PATIENT'S BODY, A CHAR ON THE TIP OF THE CATHETER WAS NOTED. NO PATIENT COMPLICATIONS WERE REPORTED AND THE PATIENT'S STATUS WAS FINE.

    Patient problems: No Consequences Or Impact To Patient

    MAUDE report 7532686 ↗
  • MalfunctionFeb 7, 2018Failure to Sense; Failure to Sense

    REPORTABLE BASED ON DEVICE ANALYSIS COMPLETED ON 23-JAN-2018. IT WAS REPORTED THAT NO SIGNAL OCCURRED. A BLAZER® II XP WAS SELECTED FOR USE. DURING PROCEDURE, WHEN THE BLAZER® WAS INSERTED INTO THE BODY AND THE CABLE WAS CONNECTED, IT WAS NOTED THAT THERE WAS NO ELECTRICAL SIGNALS. THE PHYSICIAN ATTEMPTED TO REPLACE THE CABLE; HOWEVER, ISSUE WAS NOT RESOLVED. FINALLY, THE PROCEDURE WAS COMPLETED WITH ANOTHER OF THE SAME DEVICE. NO PATIENT COMPLICATIONS WERE REPORTED AND THE PATIENT'S STATUS WAS STABLE. HOWEVER, DEVICE ANALYSIS REVEALED THAT THE SEALS ON RING 2 AND RING 3 WERE COMPROMISED.

    Patient problems: No Consequences Or Impact To Patient

    MAUDE report 7248263 ↗
  • MalfunctionJan 25, 2018Device Operates Differently Than Expected; Device Operates Differently Than Expected

    REPORTABLE BASED ON DEVICE ANALYSIS COMPLETED ON 12-JAN-2018. IT WAS REPORTED THAT THE CATHETER CURVE WOULD NOT STEER PROPERLY. A 7 / 110 / 2.5 / 8-8 BLAZER® II XP WAS SELECTED FOR USE. DURING THE PROCEDURE, IT WAS NOTED THAT THE CATHETER CURVE WOULD NOT STEER PROPERLY IN ONE DIRECTION. THE PROCEDURE WAS COMPLETED WITH ANOTHER OF THE SAME DEVICE. NO PATIENT COMPLICATIONS WERE REPORTED. HOWEVER, DEVICE ANALYSIS REVEALED THAT THE SEALS OF RINGS 2 AND 3 WERE COMPROMISED.

    Patient problems: No Consequences Or Impact To Patient

    MAUDE report 7219860 ↗
  • MalfunctionDec 18, 2017Break; Break

    REPORTABLE BASED ON DEVICE ANALYSIS COMPLETED ON 04-DEC-2017. IT WAS REPORTED THAT A CATHETER STEERING ISSUE OCCURRED. A 7 / 110 / 2.5 / 8-8 QD K2 HTD BLAZER® II XP ABLATION CATHETER WAS SELECTED FOR USE; HOWEVER, IT WAS NOTED THAT THE DIRECTION OF THE CATHETER WAS NOT FUNCTIONING PROPERLY. THE PROCEDURE WAS COMPLETED WITH A DIFFERENT DEVICE. NO PATIENT COMPLICATIONS REPORTED. HOWEVER, DEVICE ANALYSIS RESULTS REVEALED THE RING 2 SEAL WAS COMPROMISED.

    Patient problems: No Known Impact Or Consequence To Patient

    MAUDE report 7126257 ↗
  • MalfunctionJan 18, 2017Failure to Deliver Energy; Failure to Deliver Energy

    REPORTABLE UPON ANALYSIS COMPLETED ON 22DEC2016. IT WAS REPORTED THAT THE DEVICE WAS UNABLE TO ABLATE. A 7 / 110 / 2.5 / 8-8 QD K2 HTD BLAZER II XP WAS SELECTED TO TREAT THE LESION. DURING THE PROCEDURE, IT WAS NOTED THAT THE DEVICE WAS UNABLE TO ABLATE. THE TEMPERATURE WAS READING AT 130 AND WAS UNABLE TO DELIVER POWER. PHYSICIAN RESET SYSTEM AND CHANGED CABLES BUT IT DID NOT CHANGE. THE DEVICE WAS THEN REMOVED AND THE PROCEDURE WAS COMPLETED WITH A DIFFERENT DEVICE. NO PATIENT COMPLICATIONS WERE REPORTED. HOWEVER, DEVICE ANALYSIS REVEALED THAT A CHAR ON THE DISTAL TIP WAS NOTED.

    Patient problems: No Consequences Or Impact To Patient

    MAUDE report 6260142 ↗

Recalls under the same FDA submission

These recalls involve devices cleared under P020025. One submission often covers many models, so check the product and lot details in each record.

  • Z-0202-2019 · Jun 20, 2018 · Open, Classified
    Boston Scientific Maestro 4000 Cardiac Ablation System, Firmware Version 5.14, Model Numbers: M00440000, M0044000D0, M0044000H0,M0044000R0, M0044000Z0,

Other catheter, percutaneous, cardiac ablation, for treatment of atrial flutter devices

All catheter, percutaneous, cardiac ablation, for treatment of atrial flutter devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page